Healthcare Equipment and Supplies
Company Overview of Molecular Detection Inc.
Molecular Detection Inc. develops and markets Detect-Ready molecular diagnostic tests for the detection of infectious diseases. It offers DETECT-READY methicillin-resistant S. aureus (MRSA) panel, a rapid detection screening test for the growing problem of MRSA and related pathogens; and MRSA swab lysis kits. The company was founded in 2007 and is based in Wayne, Pennsylvania with an additional office in Tunbridge Wells, United Kingdom and a research operations and manufacturing facility in Jerusalem, Israel.
400 East Lancaster Avenue
Wayne, PA 19087
Founded in 2007
Key Executives for Molecular Detection Inc.
Similar Private Companies By Industry
|.decimal, Inc.||United States|
|20/20 GeneSystems Inc.||United States|
|20/20 Imaging LLC||United States|
|21st Century Scientific, Inc.||United States|
|21X Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Molecular Detection Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.